Nuklearmedizin 2019; 58(02): 160
DOI: 10.1055/s-0039-1683637
Poster
Präklinische Bildgebung
Georg Thieme Verlag KG Stuttgart · New York

Continuous Blood-Sampling in small animal [18F]FDG-PET/CT measurements

T Mann
1   Rostock University Medical Center, Institute of Anatomy, Rostock
,
BJ Krause
2   Rostock University Medical Center, Department of Nuclear Medicine, Rostock
,
A Hawlitschka
1   Rostock University Medical Center, Institute of Anatomy, Rostock
,
J Stenzel
3   Rostock University Medical Center, Core Facility Multimodal Small Animal Imaging, Rostock
,
T Lindner
3   Rostock University Medical Center, Core Facility Multimodal Small Animal Imaging, Rostock
,
S Polei
3   Rostock University Medical Center, Core Facility Multimodal Small Animal Imaging, Rostock
,
A Hohn
2   Rostock University Medical Center, Department of Nuclear Medicine, Rostock
,
A Wree
1   Rostock University Medical Center, Institute of Anatomy, Rostock
,
J Kurth
2   Rostock University Medical Center, Department of Nuclear Medicine, Rostock
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
27. März 2019 (online)

 
 

    Ziel/Aim:

    Small animal positron emission tomography/computed tomography (PET/CT) is an important preclinical tool to analyze disease mechanisms. Alterations in glucose utilization are associated with neurodegeneration and can be measured in [18F]FDG-PET/CT studies. Current analyzing strategies for small animal [18F]FDG-PET/CT Data do not facilitate full quantification as kinetic information of the blood radioactivity is usually missing. A continuous measurement of the blood tracer concentration might enable quantification but is technically challenging.

    Methodik/Methods:

    Hemiparkinsonism (Hemi-PD) was unilaterally induced in Wistar rats. 24 microgram of the toxin 6-OHDA were injected into the right medial forebrain bundle (hemi-PD rats, n = 10). Control animals were injected with carrier solution (n = 9). Before the PET/CT scan an arteriovenous (a-v) shunt was positioned between arteria and vena femoralis. The tracer [18F]FDG was injected into the a-v shunt and a dynamic PET/CT measurement was performed over 60 min. The time-course of radioactivity in blood (arterial input curve) was measured simultaneously to the PET/CT scan via the a-v shunt using a detector pump system (Twilight, Swisstrace). Standardized Uptake Values (SUVs) in the striatum were calculated with the software PMOD. In a second approach, kinetic modeling was implemented with the arterial input curve and cerebral metabolic rates (CMRglu) were calculated.

    Ergebnisse/Results:

    The striatal SUV was (mean ± SD) 1.92 ± 0.43/1.74 ± 0.41 g/ml (left/right hemisphere) in control rats and 2.13 ± 0.41/2.05 ± 0.37 g/ml (left/right hemisphere) in hemi-PD rats. The striatal CMRglu was (mean ± SD) 32.17 ± 8.5/31.53 ± 8.0 mmol/min/100 g (left/right hemisphere) in control rats and 35.05 ± 5.1/32.95 ± 5.2 mmol/min/100 g (left/right hemisphere) in hemi-PD rats. The level of significance p in hemi-PD rats was 0.8714 for SUV values and 0.6749 for CMRglu values.

    Schlussfolgerungen/Conclusions:

    Quantification of small animal [18F]FDG-PET/CT Data is feasible using an arterial input curve derived by continuous Blood-Sampling. Hemi-PD rats showed a tendency of decreased glucose utilization in the striatum which can be interpreted as a decrease in neuronal activity.


    #